Advertisement
Advertisement

GBIO

GBIO logo

Generation Bio Co. Common Stock

5.59
USD
Sponsored
-0.02
-0.27%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

5.67

+0.07
+1.32%

GBIO Earnings Reports

Positive Surprise Ratio

GBIO beat 11 of 22 last estimates.

50%

Next Report

Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
$442.00K
/
-$5.00
Implied change from Q3 25 (Revenue/ EPS)
-72.27%
/
+509.76%
Implied change from Q4 24 (Revenue/ EPS)
-89.45%
/
+56.25%

Generation Bio Co. Common Stock earnings per share and revenue

On Nov 05, 2025, GBIO reported earnings of -0.82 USD per share (EPS) for Q3 25, beating the estimate of -3.23 USD, resulting in a 74.68% surprise. Revenue reached 1.59 million, compared to an expected 673.20 thousand, with a 136.78% difference. The market reacted with a -3.28% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -5.00 USD, with revenue projected to reach 442.00 thousand USD, implying an increase of 509.76% EPS, and decrease of -72.27% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Generation Bio Co. Common Stock reported EPS of -$0.82, beating estimates by 74.68%, and revenue of $1.59M, 136.78% above expectations.
The stock price moved down -3.28%, changed from $5.19 before the earnings release to $5.02 the day after.
The next earning report is scheduled for Mar 11, 2026.
Based on 7 analysts, Generation Bio Co. Common Stock is expected to report EPS of -$5.00 and revenue of $442.00K for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement